Navigation Links
Research demystifies treatment by manipulation of spine by chiropractors in the UK

Treatment of back and neck pain by spine manipulation appears of little use as per a study. This is done by osteopaths and chiropractors in the UK to relieve many different types of pain,// as well as conditions such as asthma and allergies.

When 16 studies were reviewed it was concluded that there is little evidence to suggest that spinal manipulation is effective for treating any medical problem.

This has been criticized by osteopaths and chiropractors. Professor Edzard Ernst and colleagues from the Peninsula Medical School in Exeter, Devon, are of the opinion, "There is little evidence that spinal manipulation is effective in the treatment of any medical condition. The findings are of concern because chiropractors and osteopaths are regulated by statute in the UK. Patients and the public at large perceive regulation as proof of the usefulness of treatment.

Previous studies have shown that regulation of chiropractors was followed by a decrease in research activity. The evidence presented here should be seen as a wake-up call to the chiropractic profession. One way forward is more rigorous clinical trials to test the efficacy of spinal manipulation. After all, the treatment is not without risk and chiropractors must demonstrate why it should be a recommendable medical treatment option." The British Chiropractic Association (BCA) said it was "disappointed" that the article had been published and said the studies reviewed had been carefully selected to reach the conclusion that spinal manipulation could not be recommended.

Mathew Cousins, of the British Osteopathic Association (BOA) said, "Spinal manipulation is a technique we use but it is not the only technique we use. One of the reviews the researchers looked at said that spinal manipulation was as effective as other treatments, such as painkillers and exercise. In this age of patient choice people have the option to choose a treatment that may mean they do not have to t ake a lot of pills, which can have their own side effects."


'"/>




Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... Illustrate, Maintain® methodology and industry-leading compliance software, The Guard®, has helped another long-time ... Rights (OCR) HIPAA audit and properly satisfy the law. , Thanks to the ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... and social campaign, “Humans With Vaginas.” The goal is to ignite conversation via ... non-toxic personal care products. The brand has declared September “Humans with Vaginas” month, ...
(Date:9/20/2017)... ... 20, 2017 , ... Medicare doesn’t have the authority to ... for their prescription drugs, according to a new comparison of drug plans by ... behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Trials I Face to Receive ... he emotionally pens his aspirations and goals to better one’s life through God. “The ... Green, while searching in all the wrong places, found a love for writing. Green ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm CORDA Investment ... 8, and Monday, September 11, off work and rolled up their sleeves to help ... to local homes to start the process of rebuilding. , CORDA founder Bonner C. ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
(Date:9/7/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... President and CEO, will be presenting at two investment conferences ... 19 th Annual Global Investment Conference on Tuesday, September ... The conference is being held at the New York Palace ...
Breaking Medicine Technology: